JP

Joon Paek

Independent Board Member at Lotte Biologics

Kyoto

Investor
VC

Invests in

Stages:

Series A
Seed

Sectors:

BioTech

Locations:

Japan

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

ファンドレイジング
ヘルスケア
新規事業開発
プロセス改善
Regenerative Medicine
Stem Cells
Tissue Engineering
Cell Culture
Biomedical Engineering
FDA
Medical Devices
R&D
Biotechnology
Biomaterials
Drug Delivery
Biocompatibility
FACS
Transfection
Fluorescence Microscopy
Confocal Microscopy

Education

Lists including Joon

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

Ignis Consulting

2024

  • Founder

    2024

Lotte

2022

  • Strategic Advisor

    2022

LB
LOTTE Biologics

2022

  • Board Member

    2022

AC
Axil Capital Partners, Axil Capital Advisors K.K.

2021

  • Principal

    2021

AJ
Abrax Japan

2021 - 2023

  • Chief Operating Officer

    2021 - 2023

Metcela, Inc.

2018 - 2022

  • Vice President

    2018 - 2022

Tissue Genesis, LLC

2008 - 2022

  • Director, Research & Development

    2008 - 2022

Tissue Genesis Institute, LLC

2006 - 2008

  • Senior Scientist

    2006 - 2008

Tissue Genesis, Inc.

2005 - 2006

  • Senior Scientist

    2005 - 2006

NL
NASA Langley Research Center

1997 - 1998

  • Chemical Engineer

    1997 - 1998